Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy

NCT00142974 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00142974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00142974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy
Lead sponsor
Novartis
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2004
Completion date
April 30, 2005
Enrollment
120
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic gastropathy